The past year brought several discoveries that focused attention on antimicrobial peptides
on epithelial surfaces. The malfunction of these substances was implicated as a cause of
airway infections in cystic fibrosis. Other highlights included new insights into the relative
selectivity of antimicrobial peptides for microbial membranes, their primary site of action.